BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188]' and Ligand = 'BDBM238905'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188]


(Homo sapiens (Human))
BDBM238905
PNG
(US9403827, 7)
Show SMILES COc1ccc(F)cc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C
Show InChI InChI=1S/C29H27Cl2FN4O2/c1-15(2)35-26-25(21-10-8-18(30)12-17(21)4)36(23-13-19(31)7-6-16(23)3)29(37)34-27(26)33-28(35)22-14-20(32)9-11-24(22)38-5/h6-15,25H,1-5H3,(H,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 531n/an/an/an/an/a25



NOVARTIS AG

US Patent


Assay Description
Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1...


US Patent US9403827 (2016)


BindingDB Entry DOI: 10.7270/Q2Z31XKH
More data for this
Ligand-Target Pair